Ruthenium complex

ID: ALA1628100

Max Phase: Preclinical

Molecular Formula: C29H40F3O5RuS

Molecular Weight: 658.77

Molecule Type: Small molecule

Associated Items:

Associated Targets(non-human)

Estrogen receptor 420 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 658.77Molecular Weight (Monoisotopic): 659.1592AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. el Amouri H, Vessières A, Vichard D, Top S, Gruselle M, Jaouen G..  (1992)  Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship.,  35  (17): [PMID:1507201] [10.1021/jm00095a006]
2. el Amouri H, Vessières A, Vichard D, Top S, Gruselle M, Jaouen G..  (1992)  Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship.,  35  (17): [PMID:1507201] [10.1021/jm00095a006]

Source